Liverpool, United Kingdom

Mark J Taylor

This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignees: Eisai R&D Management Co., Ltd., Liverpool School of Tropical Medicine, University of Liverpool. Active years: 2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Mark J Taylor. Retrieved from https://idiyas.com/inventor/mark-j-taylor-ppn4jhr9

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

 

Average Co-Inventor Count = 5.0

ph-index = 1


Company Filing History:


Years Active: 2026

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: Mark J Taylor: Innovator in Anti-Wolbachia Compounds

Introduction

Mark J Taylor is a notable inventor based in Liverpool, GB. He has made significant contributions to the field of pharmaceutical sciences, particularly in the development of compounds aimed at treating filarial worm infections. His innovative work has implications for public health and disease prevention.

Latest Patents

Mark J Taylor holds a patent for "Anti-wolbachia pyrido[2,3-d]pyrimidine compounds." This invention relates to compounds of Formulae I and II, along with their salts and solvates. The patent also encompasses pharmaceutical compositions that include these compounds and their use in treating or preventing filarial worm infections, as well as other diseases associated with such infections.

Career Highlights

Throughout his career, Mark has been associated with prestigious institutions such as the University of Liverpool and the Liverpool School of Tropical Medicine. His work in these organizations has allowed him to focus on research that addresses critical health issues.

Collaborations

Mark has collaborated with esteemed colleagues, including Weiqian David Hong and Stephen A Ward. These partnerships have enhanced his research efforts and contributed to the advancement of his innovative projects.

Conclusion

Mark J Taylor's contributions to the field of pharmaceutical compounds demonstrate his commitment to addressing significant health challenges. His patent on anti-wolbachia compounds is a testament to his innovative spirit and dedication to improving public health.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…